摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-bis(4-dimethylamino-2-methylquinolin-6-yl)amino-6-(pyridin-4-yl)methylamino-[1,3,5]triazine | 462649-38-3

中文名称
——
中文别名
——
英文名称
2,4-bis(4-dimethylamino-2-methylquinolin-6-yl)amino-6-(pyridin-4-yl)methylamino-[1,3,5]triazine
英文别名
2-N,4-N-bis[4-(dimethylamino)-2-methylquinolin-6-yl]-6-N-(pyridin-4-ylmethyl)-1,3,5-triazine-2,4,6-triamine
2,4-bis(4-dimethylamino-2-methylquinolin-6-yl)amino-6-(pyridin-4-yl)methylamino-[1,3,5]triazine化学式
CAS
462649-38-3
化学式
C33H35N11
mdl
——
分子量
585.715
InChiKey
FNTRTKFISWANHN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    44
  • 可旋转键数:
    9
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    120
  • 氢给体数:
    3
  • 氢受体数:
    11

文献信息

  • Chemical derivatives and their application as antitelomerease agent
    申请人:——
    公开号:US20030087931A1
    公开(公告)日:2003-05-08
    The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
    本发明涉及癌症治疗和具有相当特异作用机制的新型抗癌药物。它还涉及新型化合物以及它们在人类中的治疗应用。
  • Chemical derivatives and their application as antitelomerase agents
    申请人:Mailliet Patrick
    公开号:US20050070571A1
    公开(公告)日:2005-03-31
    The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
    本发明涉及癌症治疗和具有相当特异作用机制的新型抗癌剂。它还涉及新型化学化合物以及它们在人类治疗方面的治疗应用。
  • CHEMICAL DERIVATIVES AND THEIR APPLICATION AS ANTITELOMERASE AGENTS
    申请人:MAILLIET Patrick
    公开号:US20090226411A1
    公开(公告)日:2009-09-10
    The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
    本发明涉及癌症治疗以及具有相当特异作用机制的新型抗癌剂。它还涉及新型化学化合物以及它们在人类治疗中的治疗应用。
  • US6887873B2
    申请人:——
    公开号:US6887873B2
    公开(公告)日:2005-05-03
  • US7482352B2
    申请人:——
    公开号:US7482352B2
    公开(公告)日:2009-01-27
查看更多